The Joint Corp (JYNT)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $95.00M
Last updated: Nov 17, 2026 at 11:06 AM ET
The Joint Corp (JYNT) Earnings: Report Dates and Results
The Joint (JYNT) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, The Joint reported EPS of $0.10, below the $0.11 estimate. It beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
JYNT has an expected report date of Mar 10, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 33.3% above the $0.06 reported for the quarter ended Dec 31, 2025.
JYNT Earnings Call
The latest JYNT earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 36 quarters below that had an estimate, JYNT beat 21, missed 14 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $13.55M, up 1.3% from $13.38M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.10 | $0.11 | $0.03 - $0.12 | -9.09% | Miss | -23.1% | 3 | 0 up, 1 down | Nov 5, 2026 | $13.55M |
| Jun 30, 2026 | -$0.01 | $0.11 | -$0.02 - $0.13 | -109.09% | Miss | N/A | 4 | 0 up, 1 down | Aug 6, 2026 | $15.18M |
| Mar 31, 2026 | $0.08 | $0.03 | -$0.02 - $0.09 | +166.67% | Beat | N/A | 4 | 0 up, 0 down | May 7, 2026 | $14.82M |
| Dec 31, 2025 | $0.06 | $0.04 | $0.02 - $0.05 | +50.00% | Beat | -63.7% | 3 | 0 up, 0 down | Mar 12, 2026 | $15.17M |
| Sep 30, 2025 | $0.13 | $0.02 | -$0.06 - $0.08 | +550.00% | Beat | +160.0% | 4 | 0 up, 0 down | Nov 6, 2025 | $13.38M |
| Jun 30, 2025 | -$0.06 | -$0.07 | -$0.11 - $0.06 | +14.29% | Beat | N/A | 4 | 0 up, 0 down | Aug 7, 2025 | $13.27M |
| Mar 31, 2025 | -$0.03 | $0.00 | -$0.05 - $0.03 | -809.09% | Miss | -133.3% | 3 | 0 up, 0 down | May 8, 2025 | $13.08M |
| Dec 31, 2024 | $0.17 | $0.02 | $0.00 - $0.03 | N/A | N/A | N/A | 2 | 0 up, 1 down | Mar 13, 2025 | $14.71M |
| Sep 30, 2024 | $0.05 | -$0.01 | -$0.05 - $0.08 | +600.00% | Beat | N/A | 5 | 0 up, 0 down | Nov 7, 2024 | $12.65M |
| Jun 30, 2024 | -$0.13 | -$0.01 | -$0.07 - $0.03 | N/A | N/A | N/A | 5 | 0 up, 0 down | Aug 8, 2024 | $12.61M |
| Mar 31, 2024 | $0.09 | -$0.01 | -$0.05 - $0.02 | +1000.00% | Beat | N/A | 5 | 0 up, 0 down | May 2, 2024 | $12.18M |
| Dec 31, 2023 | -$0.75 | $0.01 | -$0.03 - $0.04 | N/A | N/A | -1975.0% | 5 | 0 up, 0 down | Mar 7, 2024 | N/A |
| Sep 30, 2023 | -$0.05 | $0.01 | $0.00 - $0.06 | -600.00% | Miss | -200.0% | 5 | 0 up, 0 down | Nov 9, 2023 | $29.47M |
| Jun 30, 2023 | -$0.01 | $0.01 | -$0.01 - $0.03 | -200.00% | Miss | -133.3% | 3 | 0 up, 0 down | Sep 13, 2023 | $29.31M |
| Mar 31, 2023 | -$0.03 | -$0.01 | -$0.04 - $0.01 | -200.00% | Miss | N/A | 5 | 0 up, 0 down | May 4, 2023 | $28.30M |
| Dec 31, 2022 | $0.04 | $0.08 | $0.05 - $0.11 | -50.00% | Miss | +300.0% | 6 | 0 up, 0 down | Mar 9, 2023 | N/A |
| Sep 30, 2022 | $0.05 | $0.06 | $0.04 - $0.07 | -16.67% | Miss | -61.5% | 6 | 0 up, 0 down | Nov 3, 2022 | $26.45M |
| Jun 30, 2022 | $0.03 | -$0.01 | -$0.06 - $0.05 | +400.00% | Beat | -83.3% | 6 | 0 up, 0 down | Aug 4, 2022 | $24.89M |
| Mar 31, 2022 | -$0.01 | $0.04 | $0.02 - $0.06 | -125.00% | Miss | -106.3% | 6 | 0 up, 1 down | May 5, 2022 | $22.24M |
| Dec 31, 2021 | $0.01 | $0.06 | $0.02 - $0.08 | -83.33% | Miss | -98.6% | 6 | 1 up, 0 down | Feb 24, 2022 | $21.25M |
| Sep 30, 2021 | $0.13 | $0.03 | $0.02 - $0.10 | +333.33% | Beat | +18.2% | 6 | N/A | Nov 4, 2021 | $20.99M |
| Jun 30, 2021 | $0.18 | $0.06 | $0.04 - $0.08 | +200.00% | Beat | +1700.0% | 6 | N/A | Aug 5, 2021 | $20.22M |
| Mar 31, 2021 | $0.16 | $0.05 | $0.03 - $0.07 | +220.00% | Beat | +166.7% | 5 | N/A | May 6, 2021 | $17.55M |
| Dec 31, 2020 | $0.72 | $0.14 | $0.12 - $0.17 | +414.29% | Beat | +700.0% | 6 | N/A | Mar 4, 2021 | $17.04M |
| Sep 30, 2020 | $0.11 | -$0.01 | -$0.04 - $0.07 | N/A | N/A | +175.0% | 6 | N/A | Nov 5, 2020 | $15.41M |
| Jun 30, 2020 | $0.01 | -$0.13 | -$0.22 - -$0.01 | +107.69% | Beat | -66.7% | 6 | N/A | Aug 6, 2020 | $12.59M |
| Mar 31, 2020 | $0.06 | $0.07 | $0.03 - $0.09 | -14.29% | Miss | -14.3% | 6 | N/A | May 7, 2020 | $13.64M |
| Dec 31, 2019 | $0.09 | $0.07 | $0.06 - $0.08 | +28.57% | Beat | +50.0% | 6 | N/A | Mar 5, 2020 | $13.88M |
| Sep 30, 2019 | $0.04 | $0.03 | $0.01 - $0.05 | +33.33% | Beat | +300.0% | 6 | N/A | Nov 7, 2019 | $12.73M |
| Jun 30, 2019 | $0.03 | $0.04 | $0.01 - $0.08 | -25.00% | Miss | +200.0% | 6 | N/A | Aug 8, 2019 | $11.17M |
| Mar 31, 2019 | $0.07 | $0.03 | $0.00 - $0.04 | +133.33% | Beat | N/A | 5 | N/A | May 9, 2019 | $10.68M |
| Dec 31, 2018 | $0.06 | $0.03 | $0.02 - $0.06 | +100.00% | Beat | N/A | 5 | N/A | Mar 7, 2019 | $9.97M |
| Sep 30, 2018 | $0.01 | $0.01 | $0.00 - $0.02 | 0.00% | In line | N/A | 4 | N/A | Nov 8, 2018 | $9.24M |
| Jun 30, 2018 | $0.01 | -$0.01 | -$0.03 - $0.01 | +200.00% | Beat | N/A | 4 | N/A | Aug 9, 2018 | $8.80M |
| Mar 31, 2018 | -$0.03 | -$0.02 | -$0.03 - -$0.02 | -50.00% | Miss | N/A | 4 | N/A | May 10, 2018 | $8.65M |
| Dec 31, 2017 | -$0.02 | -$0.03 | -$0.03 - -$0.03 | +33.33% | Beat | N/A | 3 | N/A | Mar 8, 2018 | $25.93M |
| Sep 30, 2017 | -$0.03 | -$0.07 | N/A | +57.14% | Beat | N/A | N/A | N/A | Nov 9, 2017 | $6.54M |
| Jun 30, 2017 | -$0.08 | -$0.10 | N/A | +20.00% | Beat | N/A | N/A | N/A | Aug 10, 2017 | $6.00M |
| Mar 31, 2017 | -$0.13 | -$0.12 | N/A | -8.33% | Miss | N/A | N/A | N/A | May 11, 2017 | $11.37M |
| Dec 31, 2016 | -$0.18 | -$0.20 | N/A | +10.00% | Beat | N/A | N/A | N/A | Mar 9, 2017 | $5.78M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $0.10, down 42.9% from the year before. It was -$0.93 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $0.10 | -42.9% |
| Dec 31, 2024 | $0.18 | N/A |
| Dec 31, 2023 | -$0.84 | -863.6% |
| Dec 31, 2022 | $0.11 | -77.1% |
| Dec 31, 2021 | $0.48 | -46.7% |
| Dec 31, 2020 | $0.90 | +291.3% |
| Dec 31, 2019 | $0.23 | +360.0% |
| Dec 31, 2018 | $0.05 | N/A |
| Dec 31, 2017 | -$0.26 | N/A |
| Dec 31, 2016 | -$0.93 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 4,200 words across 5 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 4,165 | 5 | |
| 2026Q2 | Jun 30, 2026 | 4,711 | 6 | |
| 2026Q1 | Mar 31, 2026 | 5,009 | 7 | |
| 2025Q4 | Dec 31, 2025 | 6,158 | 8 | |
| 2025Q3 | Sep 30, 2025 | 4,975 | 8 | |
| 2025Q2 | Jun 30, 2025 | 5,304 | 8 | |
| 2025Q1 | Mar 31, 2025 | 4,123 | 8 | |
| 2024Q3 | Sep 30, 2024 | 4,112 | 6 |
2026Q3 Earnings Call
Opening remarks
Richard Land Conference Call Host Thank you, Danielle, and good afternoon, everyone. Joining us on the call today are President and CEO Sanjiv Razdan and CFO Scott Baumann. Please note we are using a slide presentation that can be found on The Joint's investor relations website. This afternoon, The Joint Corp. issued a press release for the third quarter ended September 30, 2026. The release is available on the company's website. Please be advised that today's discussion, including any financial and related guidance, will include forward-looking statements as defined by securities laws. These statements are based on information currently available to us and involve risks and uncertainties that could cause actual future results, performance, and business prospects and opportunities to differ materially from those expressed in or implied by these statements. Some important factors that could cause such differences are discussed in the Risk Factors section of The Joint Corp.'s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date the statements are made, and the company assumes no obligation to update them, except to the extent required by applicable securities laws. Management uses non-GAAP financial measures such as EBITDA, adjusted EBITDA, and free cash flow. A description of these measures is included in the press release issued earlier this afternoon, and reconciliations to the most directly comparable GAAP measures are included in the appendix to the presentation and press release, both available in the Investors tab of our website. With that, I will now turn the call over to Sanjiv Razdan. Sanjiv, please go ahead.
Sanjiv Razdan President and CEO Thank you, Richard, and good afternoon, everyone. Our third-quarter results show that the actions we have taken to strengthen patient engagement and reshape our operating model are beginning to work together. We are encouraged by progress in several of our leading patient metrics, while recognizing that the consumer environment continues to weigh on spending and our comparable sales. Our active membership count grew during the quarter as our initiative to win back lapsed patients gained momentum. Patients are also staying with us longer and spending more over the course of their relationship with The Joint, supporting higher patient lifetime value. At the same time, ongoing pressure on consumer spending led to fewer new patients and lower average patient spend per month, which weighed on comp sales. Comp sales were down 1.9% in the third quarter, improving from down 2.8% in the second quarter and down 4.2% in the first quarter. Financially, we continue to see the benefits of our capital-light model, with revenue growth and stronger profitability from continuing operations. Scott will walk through the results in more detail.
Frequently Asked Questions About JYNT
When is The Joint's next earnings date?
The Joint's next earnings report is expected for Mar 10, 2027.
Did JYNT beat earnings estimates last quarter?
No. The Joint reported EPS of $0.10 for the quarter ended Sep 30, 2026, below the $0.11 estimate by 9.09%.
What EPS do analysts expect from JYNT next quarter?
The consensus EPS estimate for The Joint for the quarter ending Dec 31, 2026 is $0.08 from 6 analysts, with estimates from $0.00 to $0.15.
How often does JYNT beat earnings estimates?
The Joint beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate, with an average surprise of +56.71%.
JYNT pages: Overview, Earnings, Forecast, Financials, Valuation